Voyageur Pharmaceuticals (CVE:VM) Trading Down 31.3% – Should You Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares dropped 31.3% during mid-day trading on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares were traded during trading, an increase of 205% from the average daily volume of 538,457 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market capitalization of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The company has a 50 day moving average price of C$0.10 and a 200-day moving average price of C$0.07.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.